Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
July 31, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
Highlights Positive interim data reported from ATH434-202 Phase 2 clinical trial showing improvement on the UMSARS Activities of Daily Living Scale and stable or improved neurological symptoms in...
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
July 31, 2024 07:30 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 12th annual Regeneron Prize for Creative Innovation (the...
LeddarTech Unveils the Future of ADAS With the European Launch of the LeddarNavigator Demo Car and Road Show
July 31, 2024 07:30 ET
|
LeddarTech inc.
QUEBEC CITY, Canada, July 31, 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-based low-level...
LeddarTech dévoile l’avenir de l’ADAS avec le lancement européen du véhicule de démonstration LeddarNavigator et sa tournée de présentation
July 31, 2024 07:30 ET
|
LeddarTech inc.
QUÉBEC, Canada, 31 juill. 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech ») (NASDAQ : LDTC), une société de logiciels automobiles qui fournit des technologies logicielles de...
Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2024 Financial Results on August 14, 2024
July 31, 2024 07:30 ET
|
Quipt Home Medical Corp.
CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory...
DBG Announces Successful Launch of its New DTC Strategy DSTLD Orders Rise 144% Since June Launch
July 31, 2024 07:30 ET
|
Digital Brands Group, Inc.
Austin, TX, July 31, 2024 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (“DBG”) (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands, today announces a successful launch...
MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
July 31, 2024 07:30 ET
|
MiNK Therapeutics
NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
SAB BIO Appoints Lucy To as Chief Financial Officer
July 31, 2024 07:30 ET
|
SAB Biotherapeutics, Inc.
SAB BIO Appoints Lucy To as Chief Financial Officer
Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024
July 31, 2024 07:30 ET
|
Ocular Therapeutix, Inc.
BEDFORD, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to improving vision in the real world through the...
Verisk Reports Second-Quarter 2024 Financial Results
July 31, 2024 07:15 ET
|
Verisk Analytics, Inc.
Consolidated revenues were $717 million, up 6.2%, and up 6.0% on an organic constant currency (OCC) basis for the second quarter of 2024.Income from continuing operations was $308 million,...